Ready to start planning your care? Call us at 646-926-0945 to make an appointment.
Memorial Sloan Kettering Cancer Center at ASCO 2026
Memorial Sloan Kettering Cancer Center (MSK) is proud to honor the work of our physician-scientists and researchers presenting at the 2026American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 to June 2 in Chicago.
Check back here throughout the five-day meeting for the latest updates, presentation highlights, news releases, and award recipients.
Schedule of MSK Presenters
Find out when MSK experts are presenting during the ASCO meeting.
MSK experts presented breakthrough findings in several areas of cancer research at the 2026 ASCO Annual Meeting. Highlights include advances in the treatment of liposarcoma, hepatocellular carcinoma, non-small cell lung cancer, prostate cancer, and multiple myeloma.
A clinical trial led by an MSK researcher found that the targeted therapy selpercatinib reduces the risk of recurrence by more than 80% for patients with early-stage non-small cell lung cancers carrying a RET gene fusion.
A clinical trial led by doctors from MSK has found that abemaciclib — a drug already approved for certain breast cancers — can significantly slow the growth of dedifferentiated liposarcoma, a rare, aggressive soft tissue cancer.
Results from EMERALD-3, a global phase 3 clinical trial, show that adding immunotherapy alongside a commonly utilized liver-directed procedure significantly delayed cancer progression in patients whose liver cancer has spread or cannot be treated with surgery.
An oral targeted therapy is showing promise for people with dedifferentiated liposarcoma (DDLPS), a rare subtype of soft tissue sarcoma, according to Memorial Sloan Kettering Cancer Center (MSK) physician-scientists. Results from the long awaited SARC041 phase 3 clinical trial were presented today at the annual American Society of Clinical Oncology (ASCO) meeting.
Connect with MSK at #ASCO26
Follow us on X and Bluesky for live updates from Chicago and use #ASCO26 to engage with us throughout the ASCO meeting.
Members of the media interested in speaking with MSK experts, please contact: Courtney Nowak Manager, Media Relations Memorial Sloan Kettering Cancer Center [email protected]
Request an appointment
Call 800-525-2225
We’re available 24 hours a day, 7 days a week (Eastern time)
